Pharmaceutical Regulatory Affairs Group Journals
The success of regulatory strategy is a smaller amount hooked in to the regulations than on how they're interpreted, applied, and communicated within companies and to outside constituents. Regulatory Affairs plays an important role within the pharmaceutical industry and is involved altogether stages of
drug development and also after drug approval and marketing. The
drug development process is a lengthy, complex and extremely costly albeit necessary process. Pharmaceutical companies use all the info accumulated during discovery and development stages so as to register the drug and thus market the drug. Throughout the event stages, pharmaceutical companies need to abide by an array of strict rules and guidelines so as to make sure safety and efficacy of the drug in humans. Regulatory professionals keep working with the authorities and different departments within the corporate so as to satisfy regulatory commitments with the
health authorities. Regulatory Affairs also ensures the level of the
marketing licence and leads life cycle extension activities like broadening the indication of the drug, modify in the formulation, modify in the dosage etc.. Regulatory Affairs is an attractive career choice for graduate students from a scientific background who enjoy communication and team work, are comfortable with multi-tasking and are eager to expand their knowledge within the wide realms of the Pharmaceutical world
High Impact List of Articles
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
David W Morris
Editorial: Clinical Investigation
-
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
David W Morris
Editorial: Clinical Investigation
-
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
David W Morris
Editorial: Clinical Investigation
-
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
David W Morris
Editorial: Clinical Investigation
-
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
David W Morris
Editorial: Clinical Investigation
-
What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
David W Morris
Editorial: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
-
Eltrombopag for the treatment of chronic immune thrombocytopenia
Stavroula Tsiara, Nichola Cooper
Review Article: Clinical Investigation
Relevant Topics in Clinical